Up to today, many pathogens still carry a high disease burden and remain elusive to prevention by means of vaccination. New approaches for the development of efficacious vaccines are one of the most pressing needs of our society. In the past, we have had important breakthroughs on the design of novel immunogens that can serve as the foundation of a vaccine for the Respiratory Syncytial Virus (RSV).